Technology
Health
Biotechnology

Alpine Immune Sciences

$6.77
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.06 (-0.88%) Today
-$0.02 (-0.29%) After Hours

Why Robinhood?

You can buy or sell ALPN and other stocks, options, ETFs, and crypto commission-free!

About

Alpine Immune Sciences, Inc. Common Stock, also called Alpine Immune Sciences, is a development-stage pharmaceutical company, which engages in the discovering of protein-based immunotherapies therapies targeting the immune synapse to treat cancer, autoimmune, and inflammatory disorders. Read More It offers Immunotherapy, Immune Synapse, vIgD Platform Technology, and TIP Program. The company was founded in 2015 and is headquartered in Seattle, WA.

Employees
48
Headquarters
Seattle, Washington
Founded
2015
Market Cap
94.90M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
17.18K
High Today
$6.87
Low Today
$6.70
Open Price
$6.80
Volume
2.16K
52 Week High
$10.57
52 Week Low
$3.66

Collections

Technology
Health
Biotechnology
Pharmaceutical
Cancer Prevention
2015 IPO
US
North America

News

Seeking AlphaMar 12

Alpine Immune Sciences (ALPN) Presents At Cowen And Company 39th Annual Health Care Conference - Slideshow

The following slide deck was published by Alpine Immune Sciences, Inc. in conjunction with this event. 1 29 Click to enlarge Notes:...

25

Earnings

-$0.88
-$0.71
-$0.54
-$0.37
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
-$0.80 per share
Actual
Available Mar 18, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.